| __timestamp | Halozyme Therapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 35942000 | 2917513 |
| Thursday, January 1, 2015 | 40028000 | 7878291 |
| Friday, January 1, 2016 | 45853000 | 8366794 |
| Sunday, January 1, 2017 | 53816000 | 6610381 |
| Monday, January 1, 2018 | 60804000 | 6556000 |
| Tuesday, January 1, 2019 | 77252000 | 6930000 |
| Wednesday, January 1, 2020 | 45736000 | 8758000 |
| Friday, January 1, 2021 | 50323000 | 10806000 |
| Saturday, January 1, 2022 | 143526000 | 9844000 |
| Sunday, January 1, 2023 | 149182000 | 13481000 |
| Monday, January 1, 2024 | 154335000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Halozyme Therapeutics, Inc. and Soleno Therapeutics, Inc. from 2014 to 2023. Over this period, Halozyme's SG&A expenses surged by over 300%, peaking in 2023, while Soleno's expenses grew by approximately 360%, albeit from a much smaller base. Notably, Halozyme's expenses in 2023 were nearly 11 times higher than Soleno's, highlighting the scale of operations and investment in administrative functions. This trend reflects Halozyme's aggressive expansion strategy, whereas Soleno maintains a leaner operational model. Understanding these financial dynamics offers insights into each company's strategic priorities and market positioning.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Incyte Corporation or Halozyme Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Halozyme Therapeutics, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Halozyme Therapeutics, Inc. Trends and Insights
Halozyme Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. vs Mesoblast Limited: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Soleno Therapeutics, Inc. vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights